In phase 1 it worked with 44% of patients it seems, it's multisite, it could be worth trying for our warrior with mCRPC (metastatic castrate resistant prostate cancer)
Phase 2 trial recruiting: revert horm... - Advanced Prostate...
Phase 2 trial recruiting: revert hormone resistance with apalutamide and ENV105
Written by
Maxone73
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
new trial for mCRPCa: ²²⁵Ac-rhPSMA-10.1 actinium
"The trial will enrol male patients with metastatic castrate-resistant prostate cancer who have...
AMG 212 Phase 1 study shows potential.
ASCO 2019: Phase 1 Study of Pasotuxizumab, a PSMA-Targeting Bispecific T cell Engager Immunotherapy...
Advances in the Treatment of Castrate Resistant Prostate Cancer
Very informative article....
Aussies will save us all: from Oz, a molecule that can (could) treat resistant prostate cancer
They will need some time still...but...
"CDKI-73 is currently being investigated in Phase 2...
Discussion of Phase 2 trial with LU-177 PSMA-617
I saw this presentation of the results of a phase 2 trial with LU-177 PSMA-617 and thought it was...
Related Posts
- New therapy (I hope I am not repeating myself)
Seviteronel (VT-464) - Durham's Innocrin Nabs FDA Fast Track OK for Prostate Cancer Drug- FDA Fast Track Designation for 225Ac-FL-020 for mCRPCa
Starting Abiraterone and predniSONE
Know anyone who radiates the prostate for those (me) who are metastatic at Dx.
